NCT01166724View on ClinicalTrials.gov

Renal Allograft Function and Histology Following Switching From A Tacrolimus to Sirolimus (SRL)-Based Immunosuppression-

PHASE3TerminatedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Kidney Transplant

Interventions

DRUG

Sirolimus

Tacrolimus to Sirolimus

DRUG

Tacrolimus

dosage per trough level

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

The Cleveland Clinic

OTHER